Biocon Subsidiary Secures USFDA Approval – Equitypandit
August 31, 2024August 31, 2024 Biocon on 31 August announced that their wholly-owned subsidiary, Biocon Pharma Ltd received US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Daptomycin for injection (500mg vial). In its regulatory filing, the company said, “This is to inform you…